DFDA

Low-dose Aspirin

Treatment for Maternal Hypertensive Disorders

Typical Dosage: 81-150 mg daily

Effectiveness
80%
Safety Score
81%
Clinical Trials
100
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
81
DangerousModerateSafe
Treatment Details
Dosage Range
81-150 mg daily
Time to Effect
Weeks-months (preventive effect)
Treatment Duration
12-16 weeks gestation until delivery
Evidence Quality
HIGH
Number Needed to Treat (NNT)
30(Treat 30 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
1000(Treat 1000 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$25
Side Effect Mgmt:$25
Total Annual:$70
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$5,000/QALY
QALYs Gained
0.005
Outcome-Based Costs
Cost per Responder
$467
Low-dose Aspirin Outcomes

for Maternal Hypertensive Disorders

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+15%
Common Side Effects
Minor bleeding (nosebleeds, bruising)
+7%
Gastrointestinal upset
+3%
Major bleeding
+0.1%

Sources:

elsevier.es
researchgate.net
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov